Suprachoroidal implantation of corticosteroid slow release implants for the treatment of cystoid macular edema
Authors:
Open Access
- 20 June 2025
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-7
Abstract
In cases of an unstable iris-lens diaphragm, intravitreal corticosteroid slow-release implants (CSRI) may accidentally migrate into the anterior chamber, leading to damage to the corneal endothelium. The purpose of this study was to evaluate the efficacy and safety of a suprachoroidal application of these primarily intravitreal implants to address this issue. In this single-center, retrospective proof of principle study, we observed consecutive cases of patients receiving dexamethasone and fluocinolon acetonide implants that were administered into the suprachoroidal space in patients with CME and instability of the iris-lens diaphragm. Treatment responses of the CME on OCT, incidence of secondary intraocular pressure increases, visual acuity and surgery related complications were evaluated. In total, 16 patients were treated and mean follow up was 1.8 ± 0.97 months. The procedure was well tolerated with no severe intraoperative or postoperative side effects. Mean central retinal thickness (CRT) decreased significantly from 563.13 to 382.12 (p = 0.002). There was no incidence of steroid induced glaucoma. Mean best corrected visual acuity (BCVA) significantly improved from 1.07 logMAR to 0.65 logMAR (p = 0.01). Suprachoroidal implantation of corticosteroid slow-release implants proves to be a safe and feasible alternative for complex eyes with CME and a disruption of the anterior-posterior segment border.Keywords
Funding Information
- Klinikum der Universität München
This publication has 17 references indexed in Scilit:
- Scleral Fixation of the Fluocinolone Acetonide Implant in Eyes with Severe Iris–Lens Diaphragm Disruption and Recalcitrant CME: The Fluocinolone-Loop-Anchoring Technique (FLAT)Ophthalmology and Therapy, 2020
- SUPRACHOROIDAL INJECTION OF TRIAMCINOLONE ACETONIDE, CLS-TA, FOR MACULAR EDEMA DUE TO NONINFECTIOUS UVEITISRetina, 2019
- The Role of Steroids in the Management of Diabetic Macular EdemaOphthalmic Research, 2019
- DEXAMETHASONE IMPLANT FOR DIABETIC MACULAR EDEMA IN NAIVE COMPARED WITH REFRACTORY EYESRetina, 2019
- Anterior segment migration of dexamethasone implantCurrent Opinion in Ophthalmology, 2017
- Scleral fixation of dexamethasone intravitreal implant (OZURDEX®) in a case of angle-supported lens implantationInternational Ophthalmology, 2013
- Zuverlässigkeit und Sicherheit von intravitrealen Ozurdex-InjektionenDer Ophthalmologe, 2013
- Effect of intravitreal dexamethasone on vitreous vancomycin concentrations in patients with suspected postoperative bacterial endophthalmitisGraefe's Archive for Clinical and Experimental Ophthalmology, 2005
- A Comparison of Retrobulbar versus Sub-Tenon's Corticosteroid Therapy for Cystoid Macular Edema Refractory to Topical MedicationsOphthalmology, 1997
- Improvement in Visual Acuity in Chronic Aphakic and Pseudophakic Cystoid Macular Edema After Treatment With Topical 0.5% Ketorolac TromethamineAmerican Journal of Ophthalmology, 1991